School of Medicine
Showing 11-20 of 25 Results
-
Sripriya Chari
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Sripriya (Priya) Chari is a CA Licensed Clinical Psychologist and Clinical Assistant Professor working with the INSPIRE Clinic at Stanford. Dr. Chari's clinical interests lie in early identification of the psychosis risk syndrome and providing evidence based psychotherapeutic interventions from a recovery oriented perspective. Prior to the INSPIRE Clinic, Dr. Chari was a clinical assessor for the North American Prodrome Longitudinal Study, aimed at studying the predictors for conversion to psychosis of youth at clinical high risk for psychosis. She also worked for Santa Clara County Department of Mental Health, in inpatient, outpatient, and forensic settings providing psychotherapy and assessment services.
-
Lu Chen
Professor of Neurosurgery and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsWhat distinguishes us humans from other animals is our ability to undergo complex behavior. The synapses are the structural connection between neurons that mediates the communication between neurons, which underlies our various cognitive function. My research program aims to understand the cellular and molecular mechanisms that underlie synapse function during behavior in the developing and mature brain, and how synapse function is altered during mental retardation.
-
Sundari Chetty
Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Chetty lab is interested in understanding the mechanisms underlying neurodevelopmental and psychiatric disorders, such as autism spectrum disorder and schizophrenia. In particular, our group has been investigating the mechanisms underlying brain overgrowth or undergrowth in these disorders using human induced pluripotent stem cell (hiPSC) technology. Changes in brain size often precede clinical symptoms, suggesting that understanding the underlying mechanisms regulating brain overgrowth or undergrowth could provide a window of opportunity for intervention or mitigation of symptoms.
Using hiPSCs from idiopathic patients as well as those with known genetic variations, we generate iPSC-derived cortical neural and oligodendroglial cells to investigate changes at the cellular, functional, and mechanistic levels using a broad range of techniques from RNA sequencing, genome editing, to functional assays in in vitro and in vivo models. The overarching goal of our research program is to identify novel therapeutic targets based on these mechanistic insights. -
Christina F. Chick
Instructor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsMy research examines the mechanistic contributions of sleep, cognition and affect to the onset and course of psychiatric disorders across the lifespan. I am particularly interested in adolescence as a period during which changes in circadian rhythm, sleep architecture, and sleep behavior co-occur with neuroendocrine development, psychosocial changes, and the onset of many psychiatric disorders. Given that sleep is a highly treatable target, increasing our understanding of the specific contributions of sleep to psychiatric symptom onset may facilitate the development of targeted interventions to mitigate the course of illness.
-
Octavio Choi, MD, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Choi is an interventional and forensic neuropsychiatrist on the Stanford faculty. He received his MD/PhD at UC-San Diego as part of NIH's Medical Scientist Training Program. He received his PhD degree in Neuroscience for work done at the Salk Institute in neural development.
Dr Choi is the founding director of Stanford's Forensic Psychiatry Fellowship Program, the first neurolaw-focused forensic fellowship in the world. As a forensic psychiatrist, Dr. Choi specializes in neurolaw, an emerging interdisciplinary field that studies the use and misuse of neuroscience-based evidence in the courtroom. His research interests include the use of functional brain imaging to discern mental states (e.g. lie detection, pain assessment), and the neural basis for moral decision making (e.g. defects in moral reasoning brain centers giving rise to psychopathy). A central question he considers is: how do advances in our knowledge of the neural basis of behavior change perceptions of how offenders should be punished? He has testified as a court-appointed expert, as well as for the prosecution and defense, in many high-profile and complex cases involving psychiatric, neurologic, medical, and medication-related legal claims. Dr. Choi is an active educator, providing seminars to students, attorneys, judges, neuroscientists and clinicians on the importance and relevance of neuroscience and the law.
Dr. Choi’s clinical interests include neuromodulatory approaches to treat psychiatric illness, such as the use of transcranial magnetic stimulation (TMS) to treat major depression. He is part of the interventional psychiatry group of Stanford Medicine, conducting clinical work and research to advance the power, precision, and scope of neuromodulation.
Dr. Choi is an experienced public speaker, and has given a number of talks to lay and professional audiences on neurolaw, the neuroscience of psychopathy, and the neuroscience of moral decision-making. He is a featured TEDx speaker on the topic "Can Neuroscience Eradicate Psychopathy?" -
Mehak Chopra
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioHer expertise lies in treating special populations such as athletes and students. She has also had training in dealing with cultural psychiatry issues. She has been trained to treat students with a variety of mental health issues – ADHD, Bipolar disorder, schizophrenia, eating disorders, insomnia, mood disorder and personality disorders.
